Skip to content
PubMed This is a summary of 5 peer-reviewed journal articles Updated

Long-Term Outlook and Progression

At a Glance

Andermann syndrome often progresses as peripheral nerve damage worsens, but the effects on walking, cognition, breathing, and development vary widely. Historical wheelchair and survival estimates cannot predict one child’s future, making individualized monitoring and supportive care essential.

Looking toward the future after a diagnosis of Andermann syndrome is one of the most difficult tasks a parent can face. It requires a delicate balance: being honest about the challenges while holding space for the fact that every child’s path is their own. While historical medical literature often described a single, severe path, we now know that there is a wider spectrum of how this condition can unfold.

Understanding Disease Progression

The clinical course of Andermann syndrome typically involves progression [1]. This means that while children continue to grow and learn, the damage to their peripheral nerves—the wiring for movement and sensation—gradually worsens over time [2].

Historically, natural history data suggested that many children transitioned to using a wheelchair for mobility during their teenage years, with some early reports estimating survival only into adulthood [2].

Important Note on Statistics: It is vital to interpret these historical estimates with extreme caution. Older data often relied on small cohorts who did not have access to the modern respiratory care, sleep ventilation (NIV), nutritional support, and airway-clearance techniques that are standard today. While modern interventions do not promise a specific lifespan, they can significantly improve safety, health, and quality of life. Current data remain limited, and no generalized statistic should be viewed as an individual life-expectancy prediction for your child.

Variability and Rare Cases

One of the most important things for parents to know is that the severity of the disease varies. Some children have been found to have two different variants on their SLC12A6 genes (compound heterozygous). While having two different variants does not by itself predict a mild course, some uncommon case reports in the medical literature have documented individuals with genetically confirmed Andermann syndrome who:

  • Maintain the ability to walk independently well into their youth [3].
  • Demonstrate higher muscle strength than typically expected, with reports of individuals still able to run [3].
  • Have near-normal or normal intellect despite the diagnosis [3][4].

These cases are important exceptions that prove a genetic diagnosis is not a rigid script. However, it is crucial to understand that genotype–phenotype correlations remain limited—meaning a doctor cannot look at your child’s specific gene variants and reliably forecast their walking ability or cognitive future.

Cognitive and Developmental Trajectories

The impact on the brain is as variable as the impact on the nerves. While many children will require specialized educational support and may face intellectual disabilities, cognitive trajectories vary [4][3].

Importantly, children with this condition generally continue to achieve developmental milestones, learning to communicate and solving problems at their own pace [5]. A loss of previously acquired cognitive or language skills is not an expected part of the basic disease progression. If your child begins to lose skills they once had, it should prompt immediate medical assessment to check for treatable causes, such as unrecognized seizures, sleep hypoventilation, infections, or nutritional issues.

Living with Uncertainty

The most honest answer a doctor can give about the long-term outlook is often “we will have to see.” This uncertainty is incredibly hard to live with. It helps to focus on the timeline of what clinicians can actually monitor over time: mobility, contractures, swallowing/nutrition, sleep, breathing, communication, and learning. By focusing on individualized care and proactive surveillance, you and your medical team can make adjustments to keep your child comfortable, engaged, and supported for as long as possible.

Common questions in this guide

What is the long-term outlook for a child with Andermann syndrome?
Andermann syndrome typically progresses because peripheral nerve damage worsens over time, but the pace and effects vary widely. Some children need increasing mobility and educational support, while uncommon reports describe people who walk independently or have near-normal intellect into youth. Historical survival estimates do not predict an individual child’s future.
Will my child eventually need a wheelchair?
Many older reports described wheelchair use by the teenage years, but these studies were small and reflect earlier supportive care. Some people with genetically confirmed Andermann syndrome have walked independently well into youth, so a child’s mobility cannot be predicted from historical averages or gene variants alone. The care team can monitor strength, walking, contractures, and other mobility changes to plan support.
Does Andermann syndrome always cause intellectual disability or loss of skills?
No. Cognitive and developmental outcomes vary: some children need specialized educational support, while uncommon reports describe near-normal or normal intellect. Children generally continue learning and reaching milestones at their own pace; losing previously acquired language or cognitive skills is not expected and should prompt immediate medical assessment.
Can SLC12A6 gene variants predict how severe Andermann syndrome will be?
Not reliably. Having two different SLC12A6 variants, called compound heterozygosity, does not by itself predict a mild course or determine future walking or cognitive ability. Doctors use the child’s clinical changes over time, along with genetic findings, to guide care.
What health problems should be monitored as Andermann syndrome progresses?
Clinicians commonly follow mobility, joint contractures, swallowing and nutrition, sleep, breathing, communication, and learning. A baseline sleep study or swallowing assessment may help identify concerns early when the care team thinks it is appropriate. New breathing, swallowing, or developmental concerns should be discussed promptly with the child’s clinicians.
Can supportive care improve my child’s outlook?
Respiratory care, noninvasive sleep ventilation, nutritional support, and airway-clearance techniques can improve safety, health, and quality of life. They do not guarantee a particular lifespan or prevent progression, but proactive monitoring can help the team respond to changing needs. Ask the care team which options fit your child.

Get notified when new evidence is published on Corpus callosum agenesis-neuronopathy syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (5)
  1. 1

    Temporal manipulation of KCC3 expression in juvenile or adult mice suggests irreversible developmental deficit in hereditary motor sensory neuropathy with agenesis of the corpus callosum.

    Flores B, Delpire E

    American journal of physiology. Cell physiology 2021; (320(5)):C722-C730 doi:10.1152/ajpcell.00594.2020.

    PMID: 33596149
  2. 2

    KCC3 axonopathy: neuropathological features in the central and peripheral nervous system.

    Auer RN, Laganière JL, Robitaille YO, et al.

    Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2016; (29(9)):962-76 doi:10.1038/modpathol.2016.90.

    PMID: 27230413
  3. 3

    Expanding the phenotype of SLC12A6-associated sensorimotor neuropathy.

    Bogdanova-Mihaylova P, McNamara P, Burton-Jones S, Murphy SM

    BMJ case reports 2021; (14(10)) doi:10.1136/bcr-2021-244641.

    PMID: 34706912
  4. 4

    A Novel Splice-Site Variant in SLC12A6 Causes Andermann Syndrome without Agenesis of the Corpus Callosum.

    Al Shibli N, Al-Maawali A, Elmanzalawy A, et al.

    Journal of pediatric genetics 2020; (9(4)):293-295 doi:10.1055/s-0039-1700975.

    PMID: 32765936
  5. 5

    A Novel Missense Mutation in SLC12A6 Impairs Ion Transport Function of the Protein to Cause Agenesis of the Corpus Callosum With Peripheral Neuropathy.

    Ahmad SR, Hanafi S

    Clinical genetics 2025; (108(2)):212-217 doi:10.1111/cge.14733.

    PMID: 39988558

This page about the long-term outlook for Andermann syndrome is for informational purposes only and does not constitute medical advice. Your child’s neurology and multidisciplinary care team can interpret their findings and recommend individualized monitoring and support.